Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors.
Clarisse DromainMarianne E PavelPhilippe RuszniewskiAlison LangleyChristine MassienEric BaudinMartyn E Caplinnull nullPublished in: BMC cancer (2019)
Retrospective registration, 18 July 2006; EudraCT: 2005-004904-35; ClinicalTrials.gov: NCT00353496 .
Keyphrases